Dapat, Ayesha M.

HRN: 21-73-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
CEFTRIAXONE 1G (VIAL)
08/07/2022
08/14/2022
IV
1gm
Q24
Pneumonia
Waiting Final Action 
08/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/10/2022
08/10/2022
IV
120
Q8
TC Massive Pleural Effusion Vs Lung Consolidation, Secondary To Parapneumonic Process, Typhoid Fever, Covid 19 Suspecy
Waiting Final Action 
08/10/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/09/2022
08/15/2022
IV
700
Q6
Massive Pleural Effusion Vs Lung Consolidation Sec To Parapneumonic Process, Typhoid Fever, Covid Suspect
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: